| Autor: |
Pramod, A., Priyanka, K., Akshay, S., Pratima, K., Rahul, M. |
| Předmět: |
|
| Zdroj: |
Journal of Cardiovascular Disease Research (Journal of Cardiovascular Disease Research); 2024, Vol. 15 Issue 9, p548-554, 7p |
| Abstrakt: |
Albumin is the most abundant plasma protein in human body. It is important to identify patients at the time of admission who are likely to have a poor outcome, so that such patients can be managed aggressively. Serum albumin is one of the simplest, reliable, inexpensive and easily available prognostic markers in patients on ventilator support. Therefore, the present study was conducted to study the use of serial serum albumin as a prognostic factor in deciding the outcome in critically ill patients on ventilator. The present study was observational cross-sectional study carried out at Department of Medicine of tertiary care centre during November 2021 to October 2022. A total of 50 patients who were admitted in ICU and requiring mechanical ventilatory support for 5 days or more were included in the study. Each patient was subjected to detailed history and physical examination. Serum albumin estimation was done on the day of admission when they were put on mechanical ventilator and subsequently on day three, day five and day 10 of their hospital stay. The statistical software namely SPSS 22.0 used for the analysis of the data. Results: Among 50 patients, majority of the patients survived 31 (62%) patients while 19 (38%) patients died. The total decline in serum albumin in the survivors from admission to day 10 is 0.86 g/dl. And in non-survivors it is 1.09 g/dl over a period of 10 days. The present study concludes that in critically ill patients, serial serum albumin levels can be used as a guide for weaning the patients from ventilator support. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
